Letter to Editor Regarding Narula et al, IBD 2017, Budenoside Use Is a Key Quality Marker in the Management of IBD
- PMID: 28644186
- DOI: 10.1097/MIB.0000000000001184
Letter to Editor Regarding Narula et al, IBD 2017, Budenoside Use Is a Key Quality Marker in the Management of IBD
Comment on
-
Trends in Narcotic and Corticosteroid Prescriptions in Patients with Inflammatory Bowel Disease in the United States Ambulatory Care Setting from 2003 to 2011.Inflamm Bowel Dis. 2017 Jun;23(6):868-874. doi: 10.1097/MIB.0000000000001084. Inflamm Bowel Dis. 2017. PMID: 28368911
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
